Biogen

Biogen is a leading American biotechnology company founded in 1978 and headquartered in Cambridge, Massachusetts, specializing in the treatment of neurological diseases and other serious conditions. The company applies deep understanding of human biology and leverages multiple modalities to advance first-in-class treatments for diseases including multiple sclerosis, Alzheimer's disease, ALS, spinal muscular atrophy, lupus, and rare diseases. With approximately 7,000 employees worldwide and therapies available in over 80 countries, Biogen is one of the oldest independent American biotechnology companies.